Fig. 1From: Improvement in mild anti-IgLON5 encephalopathy without immunotherapy: a case reportIgLON5 antibody cell-based assay. a Supplement: a IgLON5 IgG antibodies 1:30 in the serum. b IgLON5 IgG antibodies 1:10 in the serum. c IgLON5 IgG antibodies negative in the CSFBack to article page